Trial intelligence / Profile preview

Fluoxetine vs placebo on quality of life after acute ischemic stroke

TCTR20181216001Not yet recruiting

Sponsor
Bhumibol Adulyadej Hospital
Start
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in ischemic stroke comparing Fluoxetine with Placebo (2 arms). Primary endpoint: Quality of life after acute ischemic stroke. Planned start Jan 2019; status: not yet recruiting.

02

Drugs

fluoxetine
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on TCTR20181216001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20181216001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call